Open Access
Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products
Nahoko UCHIYAMA
1
,
Satoru Matsuda
1
,
Maiko KAWAMURA
1
,
Yoshihiko Shimokawa
1
,
Ruri KIKURA-HANAJIRI
1
,
K. Aritake
2
,
Yoshihiro Urade
2
,
Yukihiro Goda
1
2
Department of Molecular Behavioral Biology, Osaka Bioscience Institute, 6-2-4 Furuedai, Suita-City, Osaka 565-0874, Japan
|
Publication type: Journal Article
Publication date: 2014-10-01
scimago Q1
wos Q1
SJR: 0.748
CiteScore: 4.6
Impact factor: 2.5
ISSN: 03790738, 18726283
PubMed ID:
24769262
Pathology and Forensic Medicine
Law
Abstract
Our continuous survey of illegal products in Japan revealed the new distribution of 15 designer drugs. We identified four synthetic cannabinoids, i.e., NNEI (1), 5-fluoro-NNEI (2), 5-chloro-NNEI (3) and NNEI indazole analog (4), and seven cathinone derivatives, i.e., MPHP (5), α-PHPP (6), α-POP (7), 3,4-dimethoxy-α-PVP (8), 4-fluoro-α-PVP (9), α-ethylaminopentiophenone (10) and N-ethyl-4-methylpentedrone (11). We also determined LY-2183240 (12) and its 2'-isomer (13), which were reported to inhibit endocannabinoid uptake, a methylphenidate analog, 3,4-dichloromethylphenidate (14), and an MDA analog, 5-APDB (15). No chemical and pharmaceutical data for compounds 3, 4, 6 and 7 had been reported, making this the first report on these compounds.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
14
16
|
|
|
Forensic Toxicology
16 publications, 22.22%
|
|
|
Forensic Science International
9 publications, 12.5%
|
|
|
Drug Testing and Analysis
8 publications, 11.11%
|
|
|
Journal of Pharmacology and Experimental Therapeutics
2 publications, 2.78%
|
|
|
International Journal of Molecular Sciences
2 publications, 2.78%
|
|
|
Molecules
2 publications, 2.78%
|
|
|
Journal of Mass Spectrometry
2 publications, 2.78%
|
|
|
Cannabis and Cannabinoid Research
1 publication, 1.39%
|
|
|
Yakugaku Zasshi
1 publication, 1.39%
|
|
|
Therapeutic Drug Monitoring
1 publication, 1.39%
|
|
|
Chemistry of Heterocyclic Compounds
1 publication, 1.39%
|
|
|
Analytical and Bioanalytical Chemistry
1 publication, 1.39%
|
|
|
Neurotoxicity Research
1 publication, 1.39%
|
|
|
International Journal of Legal Medicine
1 publication, 1.39%
|
|
|
Russian Chemical Bulletin
1 publication, 1.39%
|
|
|
Analytical Sciences
1 publication, 1.39%
|
|
|
Psychopharmacology
1 publication, 1.39%
|
|
|
Drug and Alcohol Dependence
1 publication, 1.39%
|
|
|
Neurochemistry International
1 publication, 1.39%
|
|
|
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
1 publication, 1.39%
|
|
|
NeuroToxicology
1 publication, 1.39%
|
|
|
TrAC - Trends in Analytical Chemistry
1 publication, 1.39%
|
|
|
Human Psychopharmacology
1 publication, 1.39%
|
|
|
Molecular Informatics
1 publication, 1.39%
|
|
|
Journal of Applied Toxicology
1 publication, 1.39%
|
|
|
Analytical Science Advances
1 publication, 1.39%
|
|
|
Magnetic Resonance in Chemistry
1 publication, 1.39%
|
|
|
Japanese Journal of Forensic Science and Technology
1 publication, 1.39%
|
|
|
Current Topics in Behavioral Neurosciences
1 publication, 1.39%
|
|
|
2
4
6
8
10
12
14
16
|
Publishers
|
5
10
15
20
25
|
|
|
Springer Nature
25 publications, 34.72%
|
|
|
Elsevier
17 publications, 23.61%
|
|
|
Wiley
15 publications, 20.83%
|
|
|
MDPI
6 publications, 8.33%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
2 publications, 2.78%
|
|
|
Mary Ann Liebert
1 publication, 1.39%
|
|
|
Pharmaceutical Society of Japan
1 publication, 1.39%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 1.39%
|
|
|
Japan Society for Analytical Chemistry
1 publication, 1.39%
|
|
|
Japanese Association of Forensic Science and Technology
1 publication, 1.39%
|
|
|
Taylor & Francis
1 publication, 1.39%
|
|
|
Walter de Gruyter
1 publication, 1.39%
|
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
72
Total citations:
72
Citations from 2024:
5
(6.95%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
UCHIYAMA N. et al. Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products // Forensic Science International. 2014. Vol. 243. pp. 1-13.
GOST all authors (up to 50)
Copy
UCHIYAMA N., Matsuda S., KAWAMURA M., Shimokawa Y., KIKURA-HANAJIRI R., Aritake K., Urade Y., Goda Y. Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products // Forensic Science International. 2014. Vol. 243. pp. 1-13.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.forsciint.2014.03.013
UR - https://doi.org/10.1016/j.forsciint.2014.03.013
TI - Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products
T2 - Forensic Science International
AU - UCHIYAMA, Nahoko
AU - Matsuda, Satoru
AU - KAWAMURA, Maiko
AU - Shimokawa, Yoshihiko
AU - KIKURA-HANAJIRI, Ruri
AU - Aritake, K.
AU - Urade, Yoshihiro
AU - Goda, Yukihiro
PY - 2014
DA - 2014/10/01
PB - Elsevier
SP - 1-13
VL - 243
PMID - 24769262
SN - 0379-0738
SN - 1872-6283
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2014_UCHIYAMA,
author = {Nahoko UCHIYAMA and Satoru Matsuda and Maiko KAWAMURA and Yoshihiko Shimokawa and Ruri KIKURA-HANAJIRI and K. Aritake and Yoshihiro Urade and Yukihiro Goda},
title = {Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products},
journal = {Forensic Science International},
year = {2014},
volume = {243},
publisher = {Elsevier},
month = {oct},
url = {https://doi.org/10.1016/j.forsciint.2014.03.013},
pages = {1--13},
doi = {10.1016/j.forsciint.2014.03.013}
}